Mark Ping Chao
Impact in
- Immunology top 0.1%
- Phagocytosis and Immune Regulation
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 31
- Phagocytosis and Immune Regulation 28
- Immune cells in cancer 7
- Complement system in diseases 5
- Immune Cell Function and Interaction 4
- Hematology 12
- Acute Myeloid Leukemia Research 11
- Co-authors
- Irving L. Weissman (24 shared papers)Ravindra Majeti (21 shared papers)Siddhartha Jaiswal (5 shared papers)Arash Ash Alizadeh (7 shared papers)Wendy W. Pang (5 shared papers)Nico van Rooijen (2 shared papers)Christopher Y. Park (5 shared papers)Kenneth D. Gibbs (1 shared paper)
- Journals
- Blood (7 papers)Proceedings of the National Academy of Sciences (4 papers)Cell (3 papers)Journal of Clinical Oncology (3 papers)New England Journal of Medicine (2 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Mark Ping Chao
52 papers receiving 11.3k citations
Mark Ping Chao's Hit Papers
Peers
Comparison fields: 5 of 112
- Immunology 7.3k
- Oncology 3.4k
- Hematology 1.4k
- Genetics 749
- Physiology 1.5k
Countries citing papers authored by Mark Ping Chao
This map shows the geographic impact of Mark Ping Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ping Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ping Chao more than expected).
Fields of papers citing papers by Mark Ping Chao
This network shows the impact of papers produced by Mark Ping Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ping Chao. The network helps show where Mark Ping Chao may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ping Chao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells Hit paper breakdown → | 2009 | 1488 |
| 2 | The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors Hit paper breakdown → | 2012 | 1410 |
| 3 | CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis Hit paper breakdown → | 2009 | 1332 |
| 4 | CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma Hit paper breakdown → | 2018 | 931 |
| 5 | Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma Hit paper breakdown → | 2010 | 920 |
| 6 | Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 Hit paper breakdown → | 2010 | 664 |
| 7 | The CD47–SIRPα pathway in cancer immune evasion and potential therapeutic implications Hit paper breakdown → | 2012 | 553 |
| 8 | 2009 | 547 | |
| 9 | First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers Hit paper breakdown → | 2019 | 497 |
| 10 | 2015 | 417 | |
| 11 | 2010 | 323 | |
| 12 | 2011 | 270 | |
| 13 | 2006 | 250 | |
| 14 | 2011 | 220 | |
| 15 | 2010 | 215 | |
| 16 | 2020 | 215 | |
| 17 | 2011 | 167 | |
| 18 | Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study Hit paper breakdown → | 2023 | 143 |
| 19 | 2012 | 130 | |
| 20 | Energy-Dense versus Routine Enteral Nutrition in the Critically Ill | 2019 | 114 |
About Mark Ping Chao
Mark Ping Chao is a scholar working on Immunology, Hematology, Genetics, Physiology and Molecular Biology, having authored 54 papers that have together received 11.6k indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (28 papers), Erythrocyte Function and Pathophysiology (11 papers), Acute Myeloid Leukemia Research (11 papers), Immune cells in cancer (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Complement system in diseases (5 papers), RNA Interference and Gene Delivery (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Immunology (7.3k citations), Oncology (3.4k citations), Hematology (1.4k citations), Genetics (749 citations) and Physiology (1.5k citations). Mark Ping Chao has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Irving L. Weissman, Ravindra Majeti, Siddhartha Jaiswal, Arash Ash Alizadeh, Wendy W. Pang, Nico van Rooijen, Christopher Y. Park, Kenneth D. Gibbs, Catriona H. M. Jamieson and David J. Traver. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Cell, Journal of Clinical Oncology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.